KCTD7 Gene Progressive Myoclonus Epilepsy Type 3 Genetic Test sale cost 4400 AED
TSEN34 Gene Pontocerebellar Hypoplasia Type 2C Genetic Test sale cost 4400 AED TSEN34 Gene Pontocerebellar Hypoplasia Type 2C Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
SRPX2 Gene Rolandic Epilepsy Mental Retardation and Speech Dyspraxia Genetic Test sale cost 4400 AED SRPX2 Gene Rolandic Epilepsy Mental Retardation and Speech Dyspraxia Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

KCTD7 Gene Progressive Myoclonus Epilepsy Type 3 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The KCTD7 gene progressive myoclonus epilepsy type 3 genetic test is a specialized diagnostic tool designed to detect mutations in the KCTD7 gene, which are associated with progressive myoclonus epilepsy type 3 (PME3), a rare and severe neurological disorder. This condition is characterized by a combination of myoclonic seizures, epileptic episodes, and, in some cases, cognitive decline. Early and accurate diagnosis through genetic testing is crucial for the management and treatment of PME3, as it allows for tailored treatment plans and helps families understand the genetic implications of the condition.

Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing the genetic material for specific mutations in the KCTD7 gene. DNA Labs UAE employs state-of-the-art technology and expertise to ensure high accuracy and reliability of the test results.

The cost of the KCTD7 gene progressive myoclonus epilepsy type 3 genetic test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of obtaining a precise diagnosis cannot be understated, as it plays a critical role in the effective management of the condition and in providing genetic counseling for affected families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

KCTD7 Gene Progressive myoclonus epilepsy type 3 Genetic Test

Are you or a loved one experiencing muscle jerks (myoclonus) and seizures (epilepsy)? It could be a result of a rare genetic disorder called progressive myoclonus epilepsy type 3 (PME3). At DNA Labs UAE, we offer a comprehensive genetic test to diagnose PME3, specifically targeting the KCTD7 gene.

Test Details

The KCTD7 gene is associated with PME3, a condition characterized by progressive muscle jerks and seizures. Our Next-Generation Sequencing (NGS) technology allows for the simultaneous analysis of multiple genes, including the KCTD7 gene. This enables us to identify any genetic variations or mutations that may be responsible for the development of PME3.

By undergoing our NGS genetic test for the KCTD7 gene, our team of healthcare professionals, including neurologists and geneticists, can determine whether you carry any genetic variations or mutations in this gene that may be causing or predisposing you to PME3. This information is crucial for diagnostic purposes, genetic counseling, and potentially targeted treatment approaches.

Test Components and Price

The KCTD7 Gene Progressive myoclonus epilepsy type 3 Genetic Test is priced at 4400.0 AED. The test requires a blood or extracted DNA sample, or alternatively, one drop of blood on an FTA Card. The report delivery typically takes 3 to 4 weeks, allowing us ample time to perform a thorough analysis using our NGS technology.

Pre Test Information

Prior to undergoing the KCTD7 Gene Progressive myoclonus epilepsy type 3 Genetic Test, it is important to provide us with the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by PME3. This helps us understand the genetic patterns and inheritance of the condition within your family.

Neurological Disorders and Genetics

The KCTD7 Gene Progressive myoclonus epilepsy type 3 Genetic Test falls under the category of neurological disorders. Our dedicated genetics department specializes in diagnosing and studying these complex conditions. By analyzing the KCTD7 gene, we can gain valuable insights into the genetic basis of PME3, allowing for more targeted and personalized treatment options.

Don’t let the symptoms of PME3 go undiagnosed. Contact our team at DNA Labs UAE today to schedule your KCTD7 Gene Progressive myoclonus epilepsy type 3 Genetic Test. Our experienced neurologists and geneticists are here to provide you with the answers and support you need.

Test Name KCTD7 Gene Progressive myoclonus epilepsy type 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for KCTD7 Gene Progressive myoclonus epilepsy type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KCTD7 Gene Progressive myoclonus epilepsy type 3
Test Details

The KCTD7 gene is associated with a condition called progressive myoclonus epilepsy type 3 (PME3). PME3 is a rare genetic disorder characterized by progressive muscle jerks (myoclonus) and seizures (epilepsy).

NGS (Next-Generation Sequencing) genetic testing refers to a method of genetic testing that allows for the simultaneous analysis of multiple genes, including the KCTD7 gene. NGS technology enables the identification of genetic variations or mutations that may be responsible for the development of PME3.

By performing an NGS genetic test for the KCTD7 gene, healthcare professionals can determine whether an individual carries any genetic variations or mutations in this gene that may be causing or predisposing them to PME3. This information can be used for diagnostic purposes, genetic counseling, and potentially targeted treatment approaches.

It is important to note that NGS genetic testing for PME3 is typically performed on individuals who exhibit symptoms of the condition or have a family history of PME3. The test is typically ordered by a healthcare professional, such as a geneticist or neurologist, and involves analyzing a blood or saliva sample for genetic variations in the KCTD7 gene.

SKU: TEST-1947 Category:

Related products